Position Statement
The Risks and Benefits of Sun Exposure in New Zealand
Introduction
In June 2005 the SunSmart Partnership (Cancer Society of New Zealand and the Health Sponsorship Council) convened a meeting of experts and key stakeholders to discuss the risks and benefits of sun exposure in New Zealand. This position statement was developed as a result of discussions at the meeting. The position statement is supported by the Cancer Society of New Zealand, the Health Sponsorship Council, Osteoporosis New Zealand, the New Zealand Dermatological Society, the National Institute of Water and Atmospheric Research (NIWA), the Ministry of Health and the New Zealand Food Safety Authority.
The position statement draws heavily on work from Australia, particularly, the Position Statement on the Risks and Benefits of Sun Exposure approved by the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia, the Australasian College of Dermatologists and the Cancer Council Australia and the Position Statement of the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia on vitamin D and Bone Health in Australia and New Zealand.
The SunSmart Partnership wishes to thank Australian colleagues in the organisations listed above for their guidance and also the members of the New Zealand Expert Advisory Group who developed the New Zealand Position Statement (listed in Appendix 1).
There are both beneficial and detrimental effects of ultraviolet radiation (UVR). Excessive UVR exposure can be damaging to health. Exposure to UVR is the cause of over 90% of all skin cancer cases1,2. Skin cancer is the most common cancer in New Zealand with an estimated 50,000 or more new cases and around 250 deaths each year3,4.
Adequate vitamin D status is essential for general health. Vitamin D is necessary for bone, joint, muscle and neurological function. The link between sunlight exposure, vitamin D levels and osteoporosis is well established5.
The main source of vitamin D in Australia and NZ is exposure to sunlight. Some UVR exposure is important for vitamin D production. Because of this, a balance is required between avoiding an increased risk of skin cancer and maintaining adequate vitamin D levels. Sensible sun protection behaviour should not put people at risk of vitamin D deficiency.
Summary of Position Statement
-
In most situations, sun protection to prevent skin cancer and sun damage to the skin is required during times when the ultraviolet index (UVI)A is raised. At such times when the UVI is higher than or equal to 3, sensible sun protection behaviour is warranted and is unlikely to put people at risk of vitamin D deficiency. When the UVI is low (1 or 2) no sun protection is required.
-
During the summer months most people should be able to achieve adequate vitamin D (blood 25-hydroxyvitamin D) levels through incidental outdoor UV exposure outside peak UV timesB.
As an example, someone who burns easily in the sun (skin type 1 or 2)C may only need 5 minutes of daily summer sun exposure before 11am and after 4pm (to the face, hands and forearms) to achieve adequate vitamin D levels whereas someone who tans more easily or has darker skin (skin type 5 or 6) will need more time e.g., up to 20 minutes.
Deliberate exposure at peak UV times is not recommended as this increases the risk of skin cancer, eye damage, and photo aging.
During winter, particularly in southern New Zealand, where UV radiation levels are dramatically lower, vitamin D status may drop below adequate levels. Additional measures to achieve adequate vitamin D status may be required particularly for those at risk of vitamin D deficiency. Summer levels of vitamin D influence winter levels of vitamin D because body stores decline in winter.
-
Certain people are at high risk of skin cancer. They include individuals who have had skin cancer, have received an organ transplant or are highly sun sensitive (photosensitive)D.
People at high risk need to have more rigorous sun protection practices and therefore should discuss their vitamin D requirements with their medical practitioner to determine if dietary supplementation rather than sun exposure is recommended.
-
Some groups in the community are at increased risk of vitamin D deficiency. These include the elderly, babies of vitamin D deficient mothers, people who are housebound or are in institutional care, people with darker skin types and those who cover their skin for religious or cultural reasons.
For people with a higher risk of vitamin D deficiency, status should be discussed with their medical practitioner.
There needs to be an appropriate response from the health sector – including policy, research, and primary care to respond to this increased risk.
-
People who have darker skin (skin types 5 and 6) are at higher risk of vitamin D insufficiency and at lower risk of skin cancer.
This may have implications for the health of Maori, Asian and Pacific communities, especially those living further south.
- The UV Index is a measure of the intensity of UV radiation. The larger the number, the more intense the UV. In New Zealand, its maximum summer value is generally about 12, but it can exceed 13 in the far North. In winter it reaches peak values of 1 or 2. Values of 10 or more should be considered as "extreme". At high altitude tropical sites (e.g. Mauna Loa Observatory, Hawaii), the UV Index can exceed 20. (From www.niwa.cri.nz)
- Peak UV times in NZ are 11.00AM – 4.00PM during daylight savings months.
- See Appendix 2 for definition of skin types.
- See Appendix 2 for definition of photosensitivity.
Vitamin D metabolism
In New Zealand the main source of vitamin D is exposure to sunlight. It is well established that vitamin D forms in the skin as a result of exposure to UVB in sunlight. However there are very few studies currently available that have investigated the amount of UVB that people require to synthesise adequate vitamin D3. It has been experimentally observed that exposure of the whole of the body surface to 10-15 minutes of noonday sun in summer at mid-latitudes (approximately 1 minimal erythemal dose for untanned skin) is comparable to 375ug (15,000 IU) of vitamin D taken orally6. These data have been scaled to infer that exposure of hands, face and arms to around one-third of a minimal erythemal dose should produce around 25ug (1,000 IU) of vitamin D. The amount of vitamin D synthesised from sunlight decreases with age and with increasing skin pigmentation. People who have darker skin (skin types 5 and 6) are at higher risk of vitamin D insufficiency and at lower risk of skin cancer because the pigment in their skin reduces UV absorption7.
Vitamin D3 and D2 made in the skin and/or ingested are transported to the liver and metabolised to 25-hydroxyvitamin D.
Vitamin D function
Several recently published studies suggest beneficial effects of sun exposure in the prevention or improvement of outcome of a number of diseases including breast, prostate and colorectal cancer, non-Hodgkin lymphoma, cardiovascular disease, diabetes and autoimmune diseases such as multiple sclerosis8,9,10,11.
The mechanism for vitamin D health-related benefits has been linked to the regulatory role of 25-hydroxyvitamin D on cellular growth both in normal and cancer cells12.
A number of New Zealand studies have shown that low vitamin D status is associated with cardiovascular disease and diabetes13,14. Although these studies found no direct association between 25-hydroxyvitamin D and obesity assessed by Body Mass Index (BMI)15,16, recent unpublished work found both abdominal obesity, as measured by waist circumference and BMI were associated with low serum vitamin D levels17.
There is insufficient evidence at present to make any recommendations related to vitamin D and cardiovascular disease, diabetes or obesity. However, recommendations should be reviewed when new evidence becomes available.
Vitamin D insufficiency and deficiency
It has been documented that vitamin D levels are lower in the obese18,19, and those with metabolic and insulin resistance syndromes20, 21.
Some groups in the community are at increased risk of vitamin D deficiency. These include the elderly, babies of vitamin D deficient mothers, people who are housebound or are in institutional care, people with darker skin types and those who cover their skin for religious or cultural reasons.
Vitamin D deficiency in children can result in rickets, characterised by bone and muscle weakness and bone deformities. For adults with low vitamin D status problems may include osteoporotic fractures, bone and joint pain, falls, muscle and bone weakness and difficulty walking22.
Vitamin D status in New Zealand
There is debate about appropriate cut-off levels for vitamin D status. For analysis of the National Nutrition Survey (NNS) data 17.5 nmol/L serum 25-hydroxyvitamin D was used as the cut-off for deficiency and 50 nmol/L serum 25-hydroxyvitamin D was used as the cut-off for insufficiency. Originally the analysis was done using 37 nmol/L serum 25-hydroxyvitamin D, but, 50 nmol/L is more consistent with overseas estimates of insufficiency.
Analysis of the NNS shows that 52% of females and 45% of males had insufficient vitamin D levels and 4% of females and 2% of males had vitamin D deficiency. There are large seasonal variations in mean vitamin D levels, ranging from 36 nmol/L in spring to 69 nmol/L in summer. For New Zealand females there is an increase in vitamin D insufficiency with age, but, the same trend is not seen in New Zealand males. vitamin D insufficiency and deficiency were highest amongst Pacific adults (females and males) followed by Maori and New Zealand European and Other23. Ethnic differences in 25-hydroxyvitamin D were also seen in an earlier New Zealand Workforce Study, where Pacific adults had the lowest levels, followed by Maori, with Europeans levels highest20.
Very little information exists on optimal vitamin D levels in children. Analysis of the Children's Nutrition Survey (CNS) shows that approximately one third of New Zealand children have levels of 25-hydroxyvitamin D of less than 37.5 nmol/L. Pacific children have the highest levels of insufficiency followed by Maori and New Zealand European24.
Vitamin D is important for bone development in infants25,26 and deficiency can lead to the development of rickets27. Vitamin D deficiency is not usually dietary in origin but due to insufficient sunlight exposure. There is a lack of data on the vitamin status of exclusively breastfed babies in New Zealand, but, most babies in New Zealand are likely to receive enough UVR exposure to maintain healthy vitamin D levels.
Mothers of breastfed infants should receive adequate advice about the need to ensure their baby has appropriate exposure to sunlight (outside of the peak UVR times). There is no evidence at present to support the routine use of vitamin D supplements for breastfed babies in New Zealand28. Babies of vitamin D deficient mothers, darker skinned babies and babies that are covered up for cultural or religious reasons may be at increased risk of vitamin D deficiency.
Elderly people in New Zealand have been found to be at increased risk of low vitamin D status, particularly those who are house-bound or in institutionalised care29,30,31,32.
UVR in New Zealand
The issues of high summer UVR and low winter UVR are of particular relevance to New Zealanders. Over our latitude range there are huge variations in daily peak UVR which in New Zealand ranges from peak UVI values of 14 in the summer in the North to less than one tenth that in the winter in the South. The main contributor to these differences is the smaller solar zenith angle (i.e. higher sun) in summer and the correspondingly shorter atmospheric path of the radiation. However, seasonal differences in Sun-Earth separation, ozone and our unpolluted air also contribute. The wide variations in day length between winter and summer, especially in the South of New Zealand contribute to even larger seasonal variations in daily dose of UVR33.
Skin cancer prevention messages in New Zealand
The Cancer Society has been actively promoting skin cancer prevention for several decades in New Zealand. In the early 1990s the Health Sponsorship Council also began promoting sun protection messages with the brand SunSmart. The two agencies now work together to promote sun protection messages under the SunSmart Partnership. The sun protection messages promoted by the Partnership are:
During daylight savings months between 11am and 4pm when the ultraviolet rays are fierce...
- Slip into a shirt and Slip into some shade;
- Slop on some sunscreen before going outdoors;
- Slap on a hat with a brim or a cap with flaps and
- Wrap on a pair of sunglasses.
In 2003 the SunSmart Partnership developed a new communications strategy to promote the UVI. The UVI is the internationally accepted measure of UVR intensity and is promoted by the World Health Organization as part of sun protection messages34. Prior to this the Cancer Society and the Health Sponsorship Council had jointly sponsored the provision of both the Burn Time and the UVI to New Zealand media for use in communicating UVR intensity. Research by the Cancer Society showed that the Burn Time was misinterpreted by the public and as a result the behaviours adopted were adding to the risk of sun burning35. Extensive qualitative research was funded by the Partnership to develop user friendly graphics and messages for the UVI36.
The sun protection messages are specified for daylight savings months. There are no sun protection messages given relating to winter months. There is no evidence that the sun protection messages promoted in New Zealand have affected vitamin D levels.
There is no known health benefit from sun exposures that result in tanning or burning. The use of sun beds and sun lamps is not recommended as there is no evidence of any health benefits and there are risks. The hypothesis that sun bed use is associated with increased risk is supported by the epidemiological data for melanoma and non-melanoma skin cancers37.
Ethnicity and Skin Type – Considerations for New Zealand
People who have darker skin (skin types 5 and 6) are at higher risk of vitamin D insufficiency and at lower risk of skin cancer. This may have implications for the health of Maori, Asian and Pacific communities. Further research is required to describe the risk related to skin cancer and vitamin D insufficiency for Maori, Pacific and Asian communities.
Skin type is more relevant than ethnicity as a basis for messages related to UV exposure. Pacific Peoples, Asian and Maori have not been targeted in sun protection messages in New Zealand. There is concern in some Maori and Pacific communities that the perception exists amongst Maori and Pacific People that they are not at risk of skin cancer (even though there is a range of skin colour for Maori and Pacific Peoples).
In New Zealand, Maori, as tangata whenua, have a special relationship with the Crown via the Treaty of Waitangi. Further consultation is required with Maori before specific recommendations can be considered.
Further consultation is also required with Pacific and Asian communities to determine how best to communicate issues of risk related to skin cancer and vitamin D insufficiency.
Alternative sources of vitamin D to sunlight
Vitamin D3 is found in small quantities in a few foods such as fatty fish (salmon, sardines and mackerel), meat (particularly liver), eggs and foods fortified with vitamin D. Adequate vitamin D is unlikely to be achieved through dietary means alone.
The food supply could potentially be used to improve vitamin D status in New Zealand, by extending the current voluntary permissions for fortification with vitamin D or by introducing mandatory fortification with vitamin D.
Where there is vitamin D deficiency or risk of deficiency, oral vitamin D supplementation may be necessary. This should be discussed with a medical practitioner.
September 2005
Appendix 1
Expert Advisory Group
Louise Reiche (New Zealand Dermatological Society)
Ailsa Goulding (Department of Medicine and Health Sciences, University of Otago)
Tim Green (Department of Human Nutrition, University of Otago)
Donna Cormack (Eru Pomare Centre, Department of Public Health, Wellington School of Medicine, University of Otago)
Marius Rademaker (Dermatologist, Waikato Hospital)
Tony Reeder (Social and Behavioural Research in Cancer Group, University of Otago)
Anne-Thea McGill (Cancer Society National Health Promotion Committee/ Human Nutrition Unit, University of Auckland)
Richard McKenzie (NIWA)
Robert Scragg (School of Population Health, University of Auckland)
Marjan van Waardenberg (Senior Analyst, Public Health Directorate, Ministry of Health)
Julia Gallagher (Osteoporosis New Zealand)
Jo Dellow (New Zealand Food Safety Authority)
Those who reviewed the position statement:
Ian Reid (Endocrinologist, University of Auckland)
Andrew Grey (Endocrinologist, University of Auckland)
John Campbell (Geriatrician, Dunedin Hospital)
Mark Weatherall (Geriatrician, Wellington Hospital)
Mary-Louise Hannah (Senior Analyst, Public Health Directorate, Ministry of Health)
Jenny Reid (New Zealand Food Safety Authority)
Mary-Jane Sneyd (Department of Preventive and Social Medicine, University of Otago)
Paul Johnston (NIWA)
Ben Liley (NIWA)
Appendix 2
| Skin type I | Always burns, never tans; sensitive to sun exposure; redheaded, freckles |
| Skin type II | Burns easily, tans minimally; fair-skinned, blue, green or gray eyes |
| Skin type III | Burns moderately, tans gradually to light brown |
| Skin type IV | Burns minimally, always tans well to moderately brown; olive skin |
| Skin type V | Rarely burns, tans profusely to dark; brown skin |
| Skin type VI | Rarely burns, least sensitive; deeply pigmented skin |
Photosensitivity
Photosensitivity reactions are another problem caused by exposure to sunlight. These can be due to medicines taken internally and medicines or toiletries applied topically to the skin. They appear as abnormal reactions to normal exposure to sunlight. For example, they might involve someone burning much more quickly than usual, or developing itching, a rash or skin discolouration on skin exposed to sunlight.
The abnormal skin response can be:
- the development of a skin rash,
- an exacerbation of an existing rash,
- an exaggerated sunburn,
- symptoms such as pruritus (itchy skin)
Related information
References:
- International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans. Solar ultraviolet radiation. Lyon: International Agency for Research on Cancer, 1992.
- Armstrong BK. How sun exposure causes skin cancer. In: Hill D, Elwood JM, English DR, Eds. Prevention of Skin Cancer. Dordrecht: Kluwer Academic Publishers, 2004.
- O’Dea D. The Costs of Skin Cancer to New Zealand. Wellington: Cancer Society of New Zealand, 2000.
- New Zealand Health Information Service. Cancer, New Registrations and Deaths. Wellington: New Zealand Health Information Service, 2004.
- Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia, Osteoporosis Australia. Vitamin D and Adult Bone Health in Australia and New Zealand: a position statement. Med J Aust 2005;182(6):281-5.
- Holick MF. McCollum Award Lecture, 1994: vitamin D new horizons for the 21st century. Am J Clin Nutr 1994;60:619-630.
- Clemens TL, Adams JS, Henderson et al. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982;1(8263):74-6.
- Van der Mei IA, Ponsonby AL, Dwyer T et al. Past exposure to sun, skin phenotype and risk of multiple sclerosis: case-control study. BMJ 2003;327(7410):316.
- Zitterman A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003;89(5):552-72.
- Hughes A-M, Armstrong BK, Vajdic C et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 2004;112:865-71.
- Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 2005;35(5):290-304.
- Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers and cardiovascular disease. Am J Clin Nutr 2004;80(S6):1678S-88.
- Scragg R, Jackson R, Holdaway I, et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D: a community-based study. Int J Epidemiol 1990;19:559-63.
- Scragg R, Holdaway I, Singh V et al. Serum 25-hydroxyvitaminD3 levels decreased in IGT and diabetes. Diab Res Clin Prac 1995;27:181-88.
- Scragg R, Holdaway I, Jackson R et al. Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. Ann Epidemiol 1992;2:697-703.
- Scragg R, Holdaway I, Singh V et al. Serum 25-hydroxyvitamin D3 is related to physical activity and ethnicity but not obesity in a multicultural workforce. ANZ J Med 1995;25:218-23.
- Personal communication A-T McGill, June, 2005.
- Wortsman J, Matsuoka LY, Chen TC et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72(3):690-3.
- Parikh SJ, Edelman M, Uwaifo GI et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004;89(3):1196-9.
- Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome “X”? Br J Nutr 1998;79(4):315-27.
- Scragg R, Sowers MF, Bell C. Serum 25-hydroxyvitamin D, diabetes and ethnicity in the third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:2813-18.
- Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia, Australasian College of Dermatologists and the Cancer Council Australia. Risks and Benefits of Sun Exposure Position Statement, 2005.
- Personal communication TJ Green, August 2005.
- Rockell JE, Green TJ, Skeaff M et al. Season and ethnicity are determinants of serum 25-hydroxyvitamin D concentrations in New Zealand children aged 5 to 14 years. J Nutr 2005;135:2602-8.
- Nakao H. Nutritional significance of human milk vitamin D in neonatal period. Kobe J Med Sci 1988;34:121-8.
- Specker BL, Valanis B, Hertzberg B et al. Sunshine exposure and serum 25-hydroxyvitamin D concentration in exclusively breast fed infants. J Pediatr 1985;107:372-6.
- Blok BH, Grant CC, McNeil AR et al. Characteristics of children with florid vitamin D deficient rickets in the Auckland region in 1998. NZ Med J 2000;113(1117):374-6.
- Ministry of Health. Food and Nutrition Guidelines for Healthy Infants and Toddlers (0-2 years). Wellington: Ministry of Health, 2000.
- Davidson CW, Merrilees MJ, McKie JS et al. Hip fracture mortality and morbidity – can we do better? NZ Med J 2001;114 (1136):329-32.
- Ley SJ, Horwath CC, Stewart JM. Attention is needed to the high prevalence of vitamin D deficiency in our older population. NZ Med J 1999;112(1101):471-2.
- McAuley KA, Jones S, Lewis-Barned NJ et al. Low vitamin D status is common among elderly Dunedin women. NZ Med J 1997;110(1048):275-7.
- McGrath N, Singh V, Cundy T. Severe vitamin D deficiency in Auckland. NZ Med J 1993;106(969):524-6.
- McKenzie R, Johnston P, Liley B. A discussion of the role of solar UV in vitamin D deficiency in New Zealanders. NIWA, July 2005 (in preparation).
- World Health Organization, World Meteorological Organization, United Nations Environment Programme, International Commission on Non-Ionising Radiation Protection. Global Solar UV Index: A Practical Guide. Geneva: WHO, 2002.
- Bulliard J-L and Reeder AI. Getting the message across: sun protection information in media weather reports in New Zealand. NZ Med J 2001;114:67-70.
- Kime, NH. Sun protection information in summer weather reports: perceptions and practices. A thesis submitted for the Master of Science in Health Promotion, Leeds Metropolitan University, UK, June 2, 2003.
- Cancer Society of New Zealand. Position Statement: Skin Cancer Prevention and Early Detection. Wellington: Cancer Society of New Zealand, 2003.
On DermNet:
Other Websites:
Books about skin diseases:
See the DermNet NZ bookstore

